MannKind (MNKD) Q4 Earnings and Revenues Surpass Estimates

MannKind (MNKD) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of$ 0.01 per share. This compares to loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 300%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 0.02 per share when it actually produced earnings of $0.02, delivering a surprise of 200%.Over the last four quarters, t ...